Details of the Drug

General Information of Drug (ID: DMNG59Y)

Drug Name

4D-310

Indication

Disease Entry	ICD 11	Status	REF
Fabry disease	5C56.01	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04519749) An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease. U.S.National Institutes of Health.
2	Clinical pipeline report, company report or official report of 4D Molecular Therapeutics